Who
Mary Thistle
Director
Company insider
Files Form 4 as: Director, Cullinan Therapeutics; Director, Q32 Bio; Director, Entrada Therapeutics; Director, Vigil Neuroscience; Director, Alaunos Therapeutics; Chief Operating Officer, Dimension Therapeutics; Sr VP & GM Reproductive Health, Viacell.
In numbers
- Trades disclosed
- 56
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 1 Mar 2006
- Last trade
- 16 Jun 2026
- Last filed
- 21 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 18 Jun 2026 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,319 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,319 at $0.00 | filing |
| 12 Jun 2026filed 21 Jul 2026 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —10,826 at $0.00 | filing |
| 12 Jun 2026filed 21 Jul 2026 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —10,826 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —9,810 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —9,810 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | TRDA Entrada Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | TRDA Entrada Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 23 Oct 2025filed 27 Oct 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —53,521 at $0.00 | filing |
| 5 Aug 2025filed 5 Aug 2025 | Vigil Neuroscienceoption or derivative | SEC FORM 4 Code D | —18,068 | filing |
| 5 Aug 2025filed 5 Aug 2025 | Vigil Neuroscienceoption or derivative | SEC FORM 4 Code D | —13,928 | filing |
| 5 Aug 2025filed 5 Aug 2025 | Vigil Neuroscienceoption or derivative | SEC FORM 4 Code D | —24,309 | filing |
| 5 Aug 2025filed 5 Aug 2025 | Vigil Neuroscienceoption or derivative | SEC FORM 4 Code D | —12,155 | filing |
| 5 Aug 2025filed 5 Aug 2025 | Vigil Neuroscience | SEC FORM 4 Code D | —5,000 | filing |
| 11 Jun 2025filed 12 Jun 2025 | TRDA Entrada Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | Vigil Neuroscience | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —12,767 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | QTTB Q32 Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —12,767 at $0.00 | filing |
| 8 Aug 2024filed 9 Aug 2024 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,743 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | TRDA Entrada Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.